在T细胞瘤中α-pinene的抗瘤活性
Masaya Abe1, Noboru Asada2, Maiko Kimura1
1Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Cancer science
|January 27, 2024
概括
通过抑制癌细胞生长和诱导亡,α-pinene在治疗T细胞恶性瘤方面表现有前途. 需要进一步的研究来探索其作为这些侵略性血液癌症治疗剂的潜力.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 自然产品 化学 化学
背景情况:
- T细胞急性白血病和淋巴瘤的预后不好,目前治疗的结果不够理想.
- 虽然α-pinene在固体瘤中表现出抗瘤作用,但它对血液恶性瘤的影响仍未得到充分研究.
研究的目的:
- 综合分析alpha-pinene作为抗瘤剂对抗T细胞恶性瘤的潜力.
- 为了评估α-pinene在抑制血液性恶性瘤增殖和诱导细胞死亡方面的疗效.
主要方法:
- 研究了α-pinene对T细胞瘤细胞系 (EL-4和Molt-4) 的影响.
- 评估alpha-pinene对细胞增殖,线粒体功能,活性氧物种 (ROS) 水平和NF-κB信号传递的影响.
- 在用α-皮治疗的EL-4细胞中量化诱导亡.
主要成果:
- 阿尔法烯显著抑制了血液性恶性瘤的扩散,特别是在EL-4和Molt-4细胞系中.
- 用α-pinene治疗诱导了线粒体功能障碍和增加了反应性氧物种的积累.
- 阿尔法-皮宁抑制了NF-κB p65核转位,最终导致EL-4细胞的大量亡.
结论:
- 在体外,α-pinene对T细胞恶性瘤具有显著的抗瘤活性.
- 该化合物的机制包括诱导线粒体功能障碍,ROS积累,并抑制NF-κB信号传递,从而导致亡.
- 作为T细胞恶性瘤的潜在治疗剂,α-pinene需要进一步研究.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
760
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
